All Activity

A federally funded study published by the American Medical Association (AMA) is adding more evidence that marijuana can serve as an effective substitute for opioids in chronic pain treatment. The study, published in the Journal of the American Medical Association (JAMA) Internal Medicine on Monday, looked at opioid prescribing trends among chronic pain patients who became involved in the New York’s medical cannabis program between 2018 and 2023. “Medical cannabis is increasingly considered a substitute for prescription opioid medications for chronic pain, driven by the urgent need for opioid alternatives to combat the ongoing epidemic,” the authors noted. To that end, their results showed that New York’s marijuana program “was associated with significantly reduced prescription opioid receipt.” The 204 participants recruited for the research project—which was led by scientists at the Montefiore Medical Center, University of Arizona and City University of New York—were all prescribed opioids for pain management and were “newly certified for medical cannabis use.” Their cannabis and opioid use was monitored over the course of 18 months. The study found that average opioid use significantly decreased in the months they incorporated marijuana into their treatment regiment. Compared to chronic pain patients who didn’t use cannabis, the marijuana patients reported 3.53 fewer morphine milligram equivalents (MME) in daily opioid use. “Chronic pain and opioid addiction are two of the most pressing health challenges in the United States,” Deepika E. Slawek, M.D., M.S., the study’s lead author, said in a press release. “Our findings indicate that medical cannabis, when dispensed through a pharmacist-supervised system, can relieve chronic pain while also meaningfully reducing patients’ reliance on prescription opioids. Supervised use of medical cannabis could be an important tool in combatting the opioid crisis.” The newly published paper itself says that “participation in NYS’s medical cannabis program was associated with reduced prescription opioid receipt during 18 months of prospective follow-up, accounting for unregulated cannabis use.” “Our study was novel in that we prospectively studied medical cannabis provision in an exceptionally medicalized program with involvement of pharmacists and clinicians,” the the authors wrote, noting the utilization of data from New York’s prescription monitoring program. “In this prospective, longitudinal cohort study, participation in NYSMCP as determined by pharmacist-reported days of medical cannabis dispensed was associated with a reduction in prescription opioid receipt,” the study says. “Our findings add to existing evidence that suggests that medical cannabis may be a substitute for prescription opioids in patients with chronic pain.” The National Institute on Drug Abuse (NIDA) financially supported the research. This represents one of a continually growing number of examples of studies indicating that cannabis could provide relief for pain and an alternative to more addictive treatment options such as prescription opioids. For example, another recent federally funded study from AMA found that legalizing marijuana for medical or recreational purposes is “significantly associated with reduced opioid use among patients diagnosed with cancer.” A separate paper published in October similarly found that medical marijuana legalization is “associated with significant reductions in opioid prescribing.” In August, meanwhile, Australian researchers published a study showing that marijuana can serve as an effective substitute for opioids in pain management treatment. Another study published earlier this year in the journal Drug and Alcohol Review found that, among drug users who experience chronic pain, daily cannabis use was linked to a higher likelihood of quitting the use of opioids—especially among men. Research published late last year also found that legalizing medical cannabis appeared to significantly reduce monetary payments from opioid manufacturers to doctors who specialize in pain, with authors finding “evidence that this decrease is due to medical marijuana becoming available as a substitute” for prescription painkillers. Other recent research also showed a decline in fatal opioid overdoses in jurisdictions where marijuana was legalized for adults. That study found a “consistent negative relationship” between legalization and fatal overdoses, with more significant effects in states that legalized cannabis earlier in the opioid crisis. Authors estimated that recreational marijuana legalization “is associated with a decrease of approximately 3.5 deaths per 100,000 individuals.” “Our findings suggest that broadening recreational marijuana access could help address the opioid epidemic,” that report said. “Previous research largely indicates that marijuana (primarily for medical use) can reduce opioid prescriptions, and we find it may also successfully reduce overdose deaths.” Another recently published report into prescription opioid use in Utah following the state’s legalization of medical marijuana found that the availability of legal cannabis both reduced opioid use by patients with chronic pain and helped drive down prescription overdose deaths statewide. Overall, results of the study indicated that “cannabis has a substantial role to play in pain management and the reduction of opioid use,” it said. The post Patients In New York’s Medical Marijuana Program Saw ‘Significantly Reduced’ Opioid Prescriptions, Federally Funded Study Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Florida senator has introduced a new bill for the 2026 session that would legalize home cultivation of marijuana for registered medical cannabis patients in the state. Sen. Carlos Smith (D) filed the legislation on Friday—one of the latest attempts to give patients a home grow option that’s allowed under most medical marijuana programs in other states across the country. This latest measure would permit qualified patients who are at least 21 years old to cultivate up to six flowering plants for personal, therapeutic use. Those patients could also buy seeds and clones from licensed dispensaries. “A qualified patient who cultivates cannabis shall ensure that the plants are secured in a manner to prevent access by unauthorized persons,” the bill text says. “The sale of patient-cultivated cannabis plants and products and cultivation of cannabis by patients beyond the limits specified in this section is subject to the penalties outlined” under existing law. If enacted into law, the bill would become law on July 1, 2026. A similar proposal was introduced at the beginning of this year by Sen. Joe Gruters (R), who is now chairman of the Republican National Committee, but it did not advance. Gruters and Kim Rivers—the CEO of Trulieve, a medical marijuana company that provided the bulk of funding for an unsuccessful cannabis legalization ballot initiative last year—also met with Preident Donald Trump ahead of his endorsement of the constitutional amendment, as well as federal rescheduling and industry banking access. Notably, Amendment 3 would not have legalized home cultivation of marijuana—a detail seized on by some critics of the industry-backed proposal. The campaign behind that initiative, Smart & Safe Florida, recently said it’s collected more than one million signatures to put a new version of the legalization measure on the 2026 ballot—and so it voluntarily declined to appeal a legal case in which a judge allowed state officials to invalidate about 200,000 petitions over a largely procedural issue. Smart & Safe filed a separate lawsuit with the state Supreme Court over another issue last month, alleging that officials are violating election laws by stalling a required review process for the measure without justification. The state has since agreed to move forward with the processing. A federal judge in August separately delivered a win to the campaign—granting “complete relief” from provisions of a law the governor signed to impose other serious restrictions on signature gathering. In March, meanwhile, two Democratic members of Congress representing Florida asked the federal government to investigate what they described as “potentially unlawful diversion” of millions in state Medicaid funds via a group with ties to Gov. Ron DeSantis (R). The money was used to fight against a citizen ballot initiative, vehemently opposed by the governor, that would have legalized marijuana for adults. The lawmakers’ letter followed allegations that a $10 million donation from a state legal settlement was improperly made to the Hope Florida Foundation, which later sent the money to two political nonprofits, which in turn sent $8.5 million to a campaign opposing Amendment 3. The governor said in February that the newest marijuana legalization measure is in “big time trouble” with the state Supreme Court, predicting it will be blocked from going before voters next year. “There’s a lot of different perspectives on on marijuana,” DeSantis said. “It should not be in our Constitution. If you feel strongly about it, you have elections for the legislature. Go back candidates that you believe will be able to deliver what your vision is on that.” “But when you put these things in the Constitution—and I think, I mean, the way they wrote, there’s all kinds of things going on in here. I think it’s going to have big time trouble getting through the Florida Supreme Court,” he said. The latest initiative was filed with the secretary of state’s office just months after the initial version failed during the November 2024 election—despite an endorsement from President Donald Trump. Smart & Safe Florida is hoping the revised version will succeed in 2026. The campaign—which in the last election cycle received tens of millions of dollars from cannabis industry stakeholders, principally the multi-state operator Trulieve—incorporated certain changes into the new version that seem responsive to criticism opponents raised during the 2024 push. For example, it now specifically states that the “smoking and vaping of marijuana in any public place is prohibited.”Another section asserts that the legislature would need to approve rules dealing with the “regulation of the time, place, and manner of the public consumption of marijuana.” Last year, the governor accurately predicted that the 2024 cannabis measure from the campaign would survive a legal challenge from the state attorney general. It’s not entirely clear why he feels this version would face a different outcome. While there’s uncertainty around how the state’s highest court will navigate the measure, a poll released in February showed overwhelming bipartisan voter support for the reform—with 67 percent of Florida voters backing legalization, including 82 percent of Democrats, 66 percent of independents and 55 percent of Republicans. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In the background, a recent poll from a Trump-affiliated research firm found that nearly 9 in 10 Florida voters say they should have the right to decide to legalize marijuana in the state. Meanwhile, a pro-legalization GOP state lawmaker recently filed a bill to amend state law to codify that the public use of marijuana is prohibited. Rep. Alex Andrade (R), the sponsor, said earlier this year that embracing cannabis reform is a way for the Republican party to secure more votes from young people. Separately, Florida medical marijuana officials are actively revoking the registrations of patients and caregivers with drug-related criminal records. The policy is part of broad budget legislation signed into law earlier this year by DeSantis. The provisions in question direct the state Department of Health (DOH) to cancel registrations of medical marijuana patients and caregivers if they’re convicted of—or plead guilty or no contest to—criminal drug charges. The post Medical Marijuana Home Cultivation Would Be Legalized In Florida Under Senator’s New Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“We are experiencing a new renaissance…of psychedelic medicine.” By Leah Romero, Source NM New Mexico Department of Health experts on Friday announced an expedited timeline for the state’s new medical psilocybin program during the program’s first advisory board meeting. The seven members of the newly formed Medical Psilocybin Advisory Board met virtually with DOH experts, state Sen. Jeff Steinborn (D-Las Cruces) and dozens of members of the public to discuss the status of the program and a draft of the program’s operational procedures. The program was created during the regular legislative session earlier this year through the passage of Senate Bill 219, cosponsored by Steinborn. The bill established the program and advisory board, as well as made the use of psilocybin legal in the state in controlled, qualified medical treatment settings. New Mexico is the third state in the country to allow psilocybin, or magic mushrooms, for therapeutic use. “We are experiencing a new renaissance…of psychedelic medicine,” Steinborn said during the board meeting. He added that other states will be watching and learning from how New Mexico’s program is established. “By definition, we’re pioneers and we’re going to learn a lot, but I also want to challenge you to not be afraid to try new things, to innovate, to make things better than maybe they’ve been in other states, in some cases.” According to the bill, patients will qualify for the psilocybin program and treatment if they are diagnosed with major treatment-resistance depression; post traumatic stress disorder; substance use disorders; end-of-life care; and other conditions approved of by the DOH. The bill also states that the program must be implemented no later than December 31, 2027. Dominick Zurlo, director of the Center for Medical Cannabis and Psilocybin, said during the meeting that the DOH has set the goal of opening the program to the public a year early. The department has also hired a program manager and are working to fill the roles of environmental scientist and compliance officer. “Because there has been such large interest in this and a push for us to try to be able to help people with psilocybin treatments earlier, we have set a goal now to have the program at least to be able to see the initial patients by the end of December of 2026,” Zurlo said. During public comment, attendees voiced support and excitement for the program’s creation. Others said they were curious about the possibility of trying the treatment when it becomes available; how the supply chain will work with local mushroom growers; and how licensing will work for medical providers. Denali Wilson, director of strategic support for the nonprofit Healing Advocacy Fund, said her organization is ready to provide input to the DOH as the program takes shape. She said its priorities are safety, a “clear code of ethics,” systems for measuring outcomes and patient affordability. “While it is important for the program to move forward with urgency, achieving the right balance of safety, affordability and equity will require careful attention and thoughtfulness,” Wilson said. “Let’s be sure that any acceleration of the regulatory timeline doesn’t unintentionally compromise patient safety, undermine long-term sustainability or limit meaningful public engagement.” This story was first published by Source NM. The post New Mexico Officials Move To Launch Psilocybin Therapy Program A Year Earlier Than Expected appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

New Hampshire lawmakers have introduced a slew of marijuana-related bills for the upcoming 2026 session, including proposals to legislatively enact adult-use legalization—or alternatively leave it up to voters to decide at the ballot. After submitting at least a dozen requests for legislative staff to draft reform marijuana and psychedelics reform bills they plan to sponsor next year, legislators have now formally prefiled multiple cannabis measures for consideration in 2026. One proposal from Rep. Jonah Wheeler (D) stands out, as it seeks to put a constitutional amendment on the state ballot that would let voters decide if they want to legalize marijuana for adults 21 and older, allowing them to “possess a modest amount of cannabis for their personal use.” The measure comes as lawmakers have had difficulty advancing legalization bills through both chambers in recent sessions, and as current Gov. Kelly Ayotte (R) has threatened to veto any such bill that reaches her desk. As a constitutional amendment, Wheeler’s proposal would need supermajority support from three-fifths of lawmakers in the House and Senate to reach the ballot, and requires no action on the part of the governor. For GOP lawmakers who might not want to take a vote to override a veto on a legalization bill from their own party’s governor, passing the amendment could be a way to circumvent that situation. If the legalization question made it to the ballot, it would need support from two-thirds of voters to be enacted. Other bills filed for 2026 include another to legalize marijuana possession stautorily, two to protect the gun rights of medical cannabis patients and another that would make it so medical marijuana dispensaries could operate on a for-profit basis, as is the case in the majority of states that have legalized the plant. There are also a few pieces of legislation aimed at regulating hemp sales—an issue that’s receiving heightened attention given that Congress passed, and President Donald Trump signed, an appropriations bill that would effectively re-criminalize most consumable hemp products. Here are the summaries of the newly filed bills: Rep. Jonah Wheeler (D)—CACR 19: relative to the personal possession of cannabis. Providing that adults 21 years of age or older shall have the right to possess a modest amount of cannabis intended for their personal consumption. Rep. Jared Sullivan (D)—HB 1235: legalizing certain quantities of cannabis. Sen. Keith Murphy (R)—SB 462: relative to the right of therapeutic cannabis patients to purchase, possess, and transfer firearms in accordance with state law. Tom Mannion (R)—HB 1446: providing that an individual’s use of therapeutic cannabis shall not disqualify the individual from the purchase, ownership, or possession of a firearm. Sen. Daniel Innis (R)—SB 479: allowing alternative treatment centers to operate for profit. Sen. Bill Gannon (R)—SB 400: relative to duties and reporting requirements of the therapeutic cannabis medical oversight board. Sen. Donovan Fenton (D)—SB 461: relative to the definition of hemp. Sen. Timothy Lang (R)—SB 485: relative to the licensure, regulation and taxation of hemp-based derivative products. Sen. Bill Gannon (R)—SB 624: restricting access to certain hemp-derived products. “It has long appeared obvious to many Granite Staters that cannabis prohibition violates our state Constitution. Article I holds that rightful government policies must be ‘founded in consent,’ so how can a policy as unpopular as cannabis prohibition possibly meet that standard?” Matt Simon, director of public and government relations at the medical marijuana provider GraniteLeaf Cannabis, told Marijuana Moment on Friday. “Sadly, lawmakers have repeatedly thwarted the will of voters on this issue, so a constitutional amendment may turn out to be not only appropriate but necessary,” he said. (Disclosure: Simon supports Marijuana Moment’s work with a monthly pledge on Patreon.) So far, proposals to reform state laws around psychedelics like psilocybin that certain lawmakers requested staff to draft have not been formally filed for the next session. In October, meanwhile, a New Hampshire House Finance subcommittee advanced a bill to allow medical marijuana dispensaries in the state to convert from non-profit organizations to for-profit businesses. Another New Hampshire House committee recently discussed plans to move forward with a bill to legalize marijuana altogether–even though members accept that it is unlikely to advance beyond the chamber given opposition in the Senate and the threat of a veto by the governor. “We know where it’s going to go. Let’s send a virtue signal,” the sponsor of the legalization proposal, Rep. Jared Sullivan (D), said during a House Commerce and Consumer Affairs Committee hearing last month. “Let them be the ones that are pissing off voters who care about this.” Sullivan ultimately made a persuasive defense of moving forward with his original bill, pointing out that the House has repeatedly passed similar legalization legislation and that the chamber should stand its ground, forcing the Senate and governor to again go on record with their opposition to a policy popular among voters. Meanwhile, after the House added provisions to a Senate-passed bill that would allow medical marijuana patients to grow cannabis at home, those measures were stripped in conference. The governor also said in August that her position on marijuana legalization would not change even if the federal government moved forward with rescheduling the plant—a policy change President Donald Trump is actively considering. “If federal law changes, I have to comply with federal law,” Ayotte said. “But my position has been, and continues to be, that we should not legalize marijuana in the future.” Photo courtesy of Mike Latimer. The post New Hampshire Lawmakers Prefile Multiple Marijuana Bills For 2026—Including Measure To Let Voters Legalize On The Ballot appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

My hotel nights often feel empty while traveling, so I searched for Escorts Near Hotel, and it changed the whole vibe of my stay. She reached on time, looked beautiful, and carried herself with class. We talked for hours and shared stories like old friends. Her presence made me feel lighter and more relaxed. The warmth she brought into the room stayed with me long after she left. Escort Near The Regent Grand Hotel Call Girls Near Seven Seas Hotel Rohini Shervani Hotel Escorts Service Escorts Service Near Southern Hotel Karol Bagh Escorts Near Sun View International Hotel Karol Bagh

DOJ memo on guns & marijuana users; Senator blocks Trump’s drug czar pick; KY gov: Medical cannabis sales “very close”; OH marijuana recriminalization Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on. Check us out on Patreon and sign up to give $25/month today: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW A newly disclosed Department of Justice guidance memo obtained by Marijuana Moment shows that officials knew the federal law denying gun rights to cannabis consumers is vulnerable to “potential litigation risk”—a revelation that comes as the Supreme Court is taking up a case on the issue. The Congressional Research Service published a report on a newly approved federal ban on hemp THC products—saying it “remains unclear if and how” the prohibition will be applied and that Drug Enforcement Administration and Food and Drug Administration officials “may lack the resources to broadly enforce” it. Sen. Michael Bennet (D-CO) blocked Republican leaders’ move to confirm Sara Carter Bailey as director of the White House Office of National Drug Control Policy on an expedited basis as part of a group of other nominees from President Donald Trump. Kentucky Gov. Andy Beshear (D) said the first medical cannabis products should be on dispensary shelves “within the next couple of weeks” and that the launch of sales is “very, very close”—pointing out that marijuana is an alternative for “people that might have otherwise been taking opioids.” The Ohio Senate is expected to vote this week on a bill to scale back the voter-approved marijuana legalization law by recriminalizing possession of cannabis purchased in another state and removing anti-discrimination protections for consumers in parental rights, organ transplants and professional licensing. The World Health Organization’s Expert Committee on Drug Dependence rejected a proposal to ease a global ban on coca leaf—even as a review showed the plant does not have any “clinically meaningful public health harms” but that its prohibition creates “substantial public health harms.” / FEDERAL A former Drug Enforcement Administration agent was indicted on federal charges of conspiring to traffic drugs and launder millions of dollars for a Mexican cartel. Sen. Kirsten Gillibrand (D-NY) will speak at a cannabis event on January 29. Rep. Ilhan Omar (D-MN) tweeted, “The cannabis industry is thriving but the communities harmed most by the War on Drugs are being left out. Today, I joined @RepTroyCarter, @RepLSimon, and @repdinatitus to introduce the RESPECT Resolution to ensure that the economic benefits are shared by those who were harmed by failed policies.” / STATES Commonwealth of the Northern Mariana Islands Gov. David Apatang (I) issued an executive order transferring marijuana regulation authority from the Commonwealth Cannabis Commission to the Alcohol Beverage and Tobacco Control Division. North Carolina Gov. Josh Stein (D) touted a grant to a hemp company. Wisconsin’s Assembly minority leader discussed public support for marijuana reform. California regulators announced recalls of marijuana products due to the presence of aspergillus and due to lack of good manufacturing practices. Separately, the Cannabis Authority Board of Directors will meet on Monday. Colorado regulators published health and safety advisories about marijuana products that exceed acceptable limits of total yeast, mold and elemental impurities. Illinois regulators filed proposed changes to medical cannabis rules. Arkansas regulators delayed action on a proposed rule to limit out-of-state companies from controlling medical cannabis businesses. Washington State regulators denied a petition to revise marijuana social equity rules. Tennessee regulators published a notice about the transition of hemp product regulation to a new agency. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Kansas City, Missouri’s mayor is proposing to ban the sale of intoxicating cannabinoids, synthetic cannabinoids, nitrous oxide, bath salts, K2 and kratom. / INTERNATIONAL Canadian officials published updated data on medical cannabis use. / SCIENCE & HEALTH A study’s results “support the role of cannabis terpenes as partial agonists at CB1R and CB2R and provide the basis for selecting terpenes or terpene mixture for affecting physiological functions involving these receptors.” A study provided “initial evidence that [psilocybin-assisted therapy] can be feasibly and safely integrated into hospice care for terminally ill patients.” / ADVOCACY, OPINION & ANALYSIS The Dallas Morning News editorial board said a new scientific review suggests Texas lawmakers should be cautious about further expanding medical cannabis access. / BUSINESS Heirloom Remedies is being ordered by a judge to pay the federal government $312,651 in damages and penalties for allegedly making misrepresentations to secure COVID-related loans. / CULTURE Jeff Bridges said his favorite odor, before he lost his sense of smell from COVID, was “some fresh weed.” Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Can the feds actually enforce the new hemp THC product ban? (Newsletter: December 8, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I like that Slope Rider rewards risk (taking tight turns, going for gift-boxes) and skill — it feels fair.

Excellent article. Very interesting to read. I really love to read such a nice article. Thanks! keep rocking. promo code for 1xbet pakistan today If more people that write articles involved themselves with writing great content like you, more readers would be interested in their writings. I have learned too many things from your article. daftar nekatwin If more people that write articles involved themselves with writing great content like you, more readers would be interested in their writings. I have learned too many things from your article. daftar nekatwin

You make so many great points here that I read your article a couple of times. Your views are in accordance with my own for the most part. This is great content for your readers. bandar slot

“You can be charged with a crime for having legal weed in a different package than what you bought. You can be charged with a crime for buying legal weed in Michigan.” By Jake Zuckerman, Signal Cleveland This story was originally published by Signal Cleveland. Sign up for their free newsletters at SignalCleveland.org/subscribe. A new law that’s likely to pass at the Statehouse next week would establish a series of minor criminal penalties for people who improperly transport or possess marijuana in Ohio, while rolling back legal protections for users in venues like child custody or professional licensing disputes. For that reason, NORML, the oldest marijuana advocacy organization in the U.S., is leading a quixotic effort to ask the Ohio Senate to reject Senate Bill 56 before a final vote next week. With the Senate’s approval, the bill would go to Gov. Mike DeWine (R) for a signature or veto. The marijuana changes come within a larger package that also imposes a comprehensive, new regulatory system on intoxicating hemp, a product that’s functionally similar to legal marijuana but sold without the age restrictions, taxes or quality controls. DeWine, a Republican who opposed relaxing Ohio’s marijuana laws, has made a public cause of the intoxicating hemp issue for more than a year now. But perhaps out of a political compromise, marijuana users have found themselves caught in the crosshairs within the hemp crackdown, according to Morgan Fox, NORML’s political director. “A lot of these things are completely nonsensical,” he said in an interview. “This is recriminalizing a lot of behavior that is relatively innocuous and has been legal for some time.” House and Senate lawmakers negotiated a final version of the legislation in a conference committee, which means the bill can no longer be changed. The House passed it last month, with a late-night 52-34 vote, where a handful of Republicans joined Democrats in opposition. Committee members described the final version as a compromise between a list of scrambled voting blocs: Democrats who don’t want new criminal penalties for run-of-the-mill users, libertarian-minded Republicans protective of the right to grow one’s own marijuana, religious conservatives who disapprove expanding the legal use of intoxicants, local governments who want their tax money, a governor seeking a crackdown on the gas station hemp retailers, and both the hemp and marijuana industries seeking market advantage. (All told, 153 lobbyists registered to work on the bill as of August, state records show.) In 2023, Ohio voters passed Issue 2 by a 57 percent to 43 percent vote, allowing for adults to lawfully use, buy, sell and possess cannabis. Those rights remain broadly intact under the bill. However, SB 56 imposes legal penalties for things like possessing marijuana in anything but its original container or buying legal marijuana in Michigan where it tends to be much cheaper. What follows is a closer look at some of those rules. Out-of-state marijuana SB 56 reclassifies what counts within the “scope of legalization” of marijuana. And by its rules, any marijuana that’s not either grown in one’s home or purchased at an in-state dispensary is illegal. Prices are far lower in the more mature cannabis market of Michigan, and SB 56 would make it illegal to bring that same substance back into Ohio. Violators could be convicted of a minor misdemeanor, which entails a maximum fine of $150 but no jail time. Fox, who lobbies on a national basis for NORML, said he’s not aware of any adult-use state that makes simple possession of cannabis that originated in a different state illegal. Driving with marijuana in the car Under the bill, drivers can transport legal marijuana by car. However, it must be stored in the trunk or, for cars without trunks, behind the last upright seat of the car. Marijuana and any paraphernalia also must be stored in its “original, unopened packaging.” Similarly, edibles must be stored in their original packaging to comply with the bill. Violations are a minor misdemeanor. “You can be charged with a crime for having legal weed in a different package than what you bought,” said Bride Rose Sweeney, one of the House Democrats’ top negotiators on the bill, during a floor speech. “You can be charged with a crime for buying legal weed in Michigan.” Lost legal protections Besides legalizing marijuana, the 2023 law approved by voters created legal protections for adults who use marijuana in a spread of civil and administrative contexts. For instance, state licensing boards can’t punish licensees solely for use of marijuana. A judge can’t strip a parent of parenting time or responsibilities solely based on marijuana use and barring clear and convincing evidence of the child’s lack of safety. Similar protections exist regarding access to medical care like an organ donation, rejections to a person as a tenant, or disqualifying them from public benefits. The bill removes almost all these protections, though users could still access public benefits (with the exception of unemployment compensation). The post Ohio Senate Expected To Vote On Bill Recriminalizing Some Marijuana Activity That Voters Legalized appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for sharing the post.. parents are worlds best person in each lives of individual..they need or must succeed to sustain needs of the family. koi toto

I recently came across your blog and have been reading along. I thought I would leave my first comment. I don't know what to say except that I have enjoyed reading. Nice blog. I will keep visiting this blog very often. bandar macau

Essentially I actually learn them a short while ago nonetheless I had put together quite a few opinions regarding this now Needed to read simple things them just as before for the reason that it is well crafted. Concrete broom finishing services surrey

“It’s unacceptable for humanity to demonize a sacred medicinal plant. It was more of a political decision than a scientific one.” By Mattha Busby, Filter The World Health Organization had a historic opportunity to ease a strict global ban on the coca leaf—a prohibition, campaigners said, with “racist and colonial” roots. But the agency has chosen not to do so. The WHO’s own expert review had detailed in September how millions of people across the Andes consume the coca leaf daily as part of a longstanding cultural practice without any significant negative effects—and that, conversely, coca control strategies are associated with substantial public health harms. And yet on December 2, the WHO’s Expert Committee on Drug Dependence (ECDD) recommended that the plant be kept in Schedule I of United Nations drug treaties—the most restrictive category of control—because coca leaves can relatively easily be converted into cocaine. “The simplicity of extracting cocaine from coca leaf and its high yield and profitability are well known,” the ECDD wrote. “The Committee also reviewed evidence of a marked increase in coca leaf cultivation and in the production of cocaine-related substances, in the context of significant, increasing public health concern about cocaine use. In that context, the Committee considered that reducing or removing existing international controls on coca leaf could pose an especially serious risk to public health.” The committee noted that a 34 percent year-on-year increase in cocaine production was reported in 2023, with some countries reporting historically high levels. But reform advocates emphasize that coca is not cocaine. They insist that the WHO’s review acknowledged both the plant’s medical potential and the lack of evidence of problematic coca leaf use anywhere in the world—two key criteria a drug must satisfy to be placed in a less restrictive schedule. “It’s unacceptable for humanity to demonize a sacred medicinal plant,” Jaison Perez Villafaña, a wisdom keeper or mamo from Colombia’s Arhuaco community, told Filter. “It was more of a political decision than a scientific one. The coca leaf (el ayu) is not itself to blame for being converted into cocaine by humans with economic interests.” The ECDD said it recognized that “coca leaf has an important cultural and therapeutic significance for Indigenous peoples and other communities and that there are exemptions for traditional use of coca leaf in certain national frameworks.” A coalition of Indigenous coca leaf producers and consumers wrote to the WHO in October urging the UN body to “clearly differentiate” between traditional coca use and issues associated with cocaine. Steve Rolles, senior policy analyst at Transform Drug Policy Foundation, called the WHO’s suggestion that keeping coca in Schedule 1 would restrict cocaine production “ridiculous,” saying the decision exposed “the moral and scientific bankruptcy pervading the entire system” of global drug control. “Whilst we may expect decisions like this to emerge from political bodies subsumed within entrenched ‘war on drugs’ narratives, there was a hope that the more objective, scientific, and nominally independent corners of the UN would maintain a degree of pragmatism and principle—even if their recommendations were later rejected by UN political entities,” he wrote on LinkedIn. “The risks of cocaine powder or smoked crack cocaine, creations of the global North, which is also by far the biggest market for both, are demonstrably of a different order to traditional coca use, chewed or in tea, which occurs exclusively in the global South,” Rolles added. “It is the global South where the burden of both the failed war on cocaine, and the criminalization of entire cultures is most acutely felt.” In 2020, following a WHO recommendation, the UN’s Commission on Narcotic Drugs voted narrowly to relax international controls on cannabis, acknowledging its medical value after decades of “reefer madness.” For reform advocates, that decision appeared to signal a slow and overdue shift toward evidence-based scheduling. Therefore there were hopes that the UN system could also distinguish between the coca leaf—containing less than 1 percent cocaine alkaloid—and the refined powder that fuels global demand. Yet coca will continue to be treated as though it has the same risk profile as cocaine—even after the WHO review affirmed that traditional coca chewing has caused no documented fatalities, is not associated with significant dependence or “abuse” potential, and has possible therapeutic applications ranging from anti-inflammatory effects to modest improvements in post-meal glucose. “The WHO’s decision is deeply disappointing and profoundly troubling,” Ann Fordham, executive director of the International Drug Policy Council, said in a press release. “This was not a routine review—it was a critical test of the UN drug control system. The Committee has shown it cannot objectively assess evidence or consider the human rights consequences of prohibition. Instead, it has chosen to reinforce the racist and colonial foundations of international drug control. This decision makes clear that the system is broken and resistant to meaningful reform.” Experts have long argued that the logic behind the coca ban is selective and ignores existing treaty precedents. Plants such as ephedra, which is used to manufacture methamphetamine, psilocybin-containing mushrooms and mescaline-producing cacti all remain unscheduled at the plant level, despite being used to produce controlled substances. While open persecution of coca-chewers in the Andes has waned, prohibition still shapes daily life in parts of the region—from farmers who lose crops to stop-start aerial fumigation campaigns, to communities caught between eradication forces and the networks that dominate the illegal cocaine trade. In the September review, the independent group of experts contracted by the WHO noted research that showed exposure to harmful glyphosate-based pesticides like Roundup, found to be a probable carcinogen, from authorities’ aerial spraying of coca crops “increased the number of miscarriages and the number of medical consultations related to dermatological and respiratory illnesses in targeted communities.” The review added that another study showed that forced coca eradication incentivized coca farmers to intensify production through increased use of toxic agro-chemicals “in remaining or subsequent coca plots, increasing their exposure to those chemicals.” Villafaña and other Indigenous leaders have warned that these pressures amount to a form of cultural violence. Coca is central to Andean communities’ spiritual practice, conflict resolution, work, ceremony and community health—yet its use outside narrow “traditional” exemptions places people at risk of criminal sanctions. “It would be a relief for us as a culture,” Villafaña said, “if the world recognized it as a sacred plant and didn’t demonize it.” But, he added, the decision would not otherwise affect his community, whose members will continue chewing coca as they always have done. This article was originally published by Filter, an online magazine covering drug use, drug policy and human rights through a harm reduction lens. Follow Filter on Bluesky, X or Facebook, and sign up for its newsletter. The post World Health Organization Won’t Ease Coca Leaf Ban, Even As Review Found Prohibition Is More Dangerous Than The Plant appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. situs togel Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. slot online Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. toto slot I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. evostoto slot Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! toto togel

I think this is a really good article. You make this information interesting and engaging. You give readers a lot to think about and I appreciate that kind of writing. codigo 1xbet I wanted to thank you for this excellent read!! I definitely loved every little bit of it. I have you bookmarked your site to check out the new stuff you post. 1xbet promo code pakistan today It is my first visit to your blog, and I am very impressed with the articles that you serve. Give adequate knowledge for me. Thank you for sharing useful material. I will be back for the more great post. 1xbet promo code india Awesome article! I want people to know just how good this information is in your article. It’s interesting, compelling content. Your views are much like my own concerning this subject. melbet promo code bd

I haven’t any word to appreciate this post.....Really i am impressed from this post....the person who create this post it was a great human..thanks for shared this with us. codigo de promocional 1xbet Thanks for posting this info. I just want to let you know that I just check out your site and I find it very interesting and informative. I can't wait to read lots of your posts. 1xbet promo code in india This content is written very well. Your use of formatting when making your points makes your observations very clear and easy to understand. Thank you. promo code for 1xbet egypt I just found this blog and have high hopes for it to continue. Keep up the great work, its hard to find good ones. I have added to my favorites. Thank You. melbet promo code free bet

Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. Document Translation Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. online gambling in Utah Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. gambling online in Utah I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. Super Bowl betting Utah Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! togel 4d

I really enjoyed the latest episode of the Green Goddess Podcast! Lisa and Tara brought such valuable insights into canna-feminism and its growing importance in our society. It's inspiring to see how cannabis can empower women and foster community. For anyone looking to relax and unwind after a deep dive into these topics, I recommend trying out the Drive Mad app for some fun driving challenges! It’s a great way to take a break!

It was wondering if I could use this write-up on my other website, I will link it back to your website though.Great Thanks. codigo promocional 1xbet mexico I’m going to read this. I’ll be sure to come back. thanks for sharing. and also This article gives the light in which we can observe the reality. this is very nice one and gives indepth information. thanks for this nice article... 1xbet promo code today sri lanka I really appreciate this wonderful post that you have provided for us. I assure this would be beneficial for most of the people. 1xbet promo code free bet pakistan Love to read it,Waiting For More new Update and I Already Read your Recent Post its Great Thanks. melbet promo code india

Nice to read your article! I am looking forward to sharing your adventures and experiences. situs slot

some genuinely choice content on this internet site , saved to my bookmarks . Berlayar Drive Condo

Some really quality blog posts on this site, saved to fav. Bayshore Drive Condo

Your focus encourages others to remain disciplined New Upper Changi Road Condo

A Democratic senator is holding up nearly 90 of President Donald Trump’s administrative nominees—including the president’s pick for White House drug czar who he says is among many “unqualified” candidates who threaten to “undermine the rule of law and our national security.” The Senate Judiciary Committee in October advanced the nomination of Sara Carter Bailey to join the administration as director of the Office of National Drug Control Policy (ONDCP). But when she was included in a en bloc confirmation package of 88 nominees for floor consideration, Sen. Michael Bennet (D-CO) raised a procedural inquiry that led Republicans to stop the vote. “I just blocked 88 Trump nominees from confirmation—including Sara Carter Bailey, a former Fox News contributor nominated to be our country’s drug czar,” Bennet said on the floor on Thursday. “Bailey was nominated by Trump, who just pardoned the former president of Honduras, as he served 45 years in prison for conspiring to distribute over 400 tons of cocaine.” “I will not allow unqualified nominees, this White House, or the president to undermine the rule of law and our national security,” he said. The procedural complaint Bennet raised has to do with the fact that ONDCP director is a “level I” executive position. As such, unlike the other nominees in the package, Bailey was ineligible to be included in the group vote—which the Republican senator presiding over the body on Thursday acknowledged. Trump tried to jam through 88 unqualified nominees including a Fox News talking head to run America’s drug policy. I blocked the nominations, and I’m running for Governor to bring that same backbone and respect for the rule of law to Colorado. https://t.co/8aPEIpSrYr — Michael Bennet (@MichaelBennet) December 4, 2025 Bailey, for her part, has voiced support for medical cannabis, while stating that she doesn’t have a “problem” with legalization, even if she might not personally agree with the policy. A former journalist known for her coverage of drug cartels, Bailey also recently advised senators that the administration is keeping “all options” on the table as it continues to consider a pending marijuana rescheduling proposal, while describing cannabis reform as a “bipartisan issue.” My statement on blocking 88 Trump nominees on the Senate floor: pic.twitter.com/jRQNdfEefv — Michael Bennet (@SenatorBennet) December 4, 2025 Bennet isn’t the only senator to question the nominee’s qualifications. Ahead of the October committee vote, Sen. Dick Durbin (D-IL), the panel’s ranking member, called Bailey a Trump “loyalist” who was “nominated for a position for which she is totally, wholly unqualified.” “She is not a physician or addiction specialist,” he said. “She has never been a prosecutor nor a law enforcement official.” Given the role of the ONDCP director in setting and carrying out the administrative agenda on drug policy issues, the fact that Bailey has gone on the record enthusiastically endorsing medical cannabis in the past is welcome news for advocates. Sen. Cory Booker (D-NJ) separately raised the issue of cannabis rescheduling with the nominee in September, stating that the proposal to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) would represents a “step in the right direction.” “It would open up the door to more scientific study, and so I’m wondering if you were confirmed, how would you advise the American president about the ongoing rescheduling process?” he asked. Bailey said she shares Booker’s passion for the issue, which she characterized as “bipartisan.” “If confirmed as director, I will comply with all federal laws and fulfill all statutory responsibilities of the ONDCP,” she said. “However, we will continue to work extensively with research and data. We will continue to do that and explore all options.” Trump endorsed rescheduling—as well as marijuana industry banking access and a Florida legalization ballot initiative–on the campaign trail ahead of his second term. But his most recent comments in late August about the timeline for a rescheduling decision gave a more ambiguous impression of his position on the issue. While Bailey has spoken often about various marijuana policy issues—focusing attention on illicit trafficking and illegal grow operations on U.S. land, for example—her public comments on how she personally feels about the topic have been limited. What she did say last year in an episode of her podcast, The Sara Carter Show, signaled that she draws a distinction between legally regulated and illicitly supplied marijuana. “I don’t have any problem if it’s legalized and it’s monitored,” she said. “I mean, I may have my own issues of how I feel about that, but I do believe that cannabis for medicinal purposes and medical reasons is a fantastic way of handling—especially for people with cancer and other illnesses, you know—of handling the illness and the side effects of the medication and those illnesses. So I’m not saying we’ve gotta make it illegal.” If Bailey is ultimately confirmed by the Senate, she will become the second drug czar in a row who has voiced support for medical marijuana, following former President Joe Biden’s ONDCP director Rahul Gupta, who worked as a consultant for a cannabis businesses and also oversaw implementation of West Virginia’s medical marijuana program. On her social media, Bailey has previously shared links—without commentary—to news stories about a variety of marijuana-related issues. In addition to her focus on illicit cartel grows, she’s also posted about congressional and state-level legalization votes, staffers in the Biden administration being fired over past cannabis use, Democratic presidential candidates’ support for legalization, the advancement of cannabis banking legislation in Congress and state policy developments such as Alaska’s legalization of cannabis cafes. Federal statute dictates the drug czar is prohibited from endorsing the legalization of Schedule I drugs in the CSA, including marijuana. “The Director…shall ensure that no Federal funds appropriated to the Office of National Drug Control Policy shall be expended for any study or contract relating to the legalization (for a medical use or any other use) of a substance listed in schedule I of section 812 of this title and take such actions as necessary to oppose any attempt to legalize the use of a substance (in any form) that— (A) is listed in schedule I of section 812 of this title; and (B) has not been approved for use for medical purposes by the Food and Drug Administration.” In April, however, Democratic congressional lawmakers announced the filing of a bill that would remove that restriction. It has not yet advanced in the GOP-controlled Congress. Bailey has separately sounded the alarm about the risk of pesticides and other contaminants in marijuana grown and sold by Chinese cartels—an issue that was recently taken up by a House committee. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Last year, the nominee talked about the issue with Derek Maltz, a then-retired Drug Enforcement Administration (DEA) official who is temporarily served as acting administrator of the agency prior to the confirmation of Trump’s permanent pick, Terrance Cole. In an X post about the interview with Maltz, Bailey said he exposed how “Chinese marijuana grow operations are using hazardous chemicals as pesticides.” In 2022, U.S. Rep. Mike Garcia (R-CA) applauded Bailey, who worked with his office to bring attention to illicit grow operations in his district, leading to a local law enforcement investigation. Bailey gave the congressman credit, saying “your work in taking down the illegal marijuana grows has stopped cartels from exploiting your community, those people forced to work on them and the [money].” In an interview with Fox News’s Sean Hannity in 2021, she also talked about her work with Garcia—including accompanying him on a helicopter to survey “miles and miles and miles of vast, sophisticated illegal grows worth tens of millions of dollars.” Cartels have “become extremely more brazen. They’re not afraid of hiding it,” she said. “They don’t hide it because they don’t feel that they’ll ever be held accountable for it.” In a sense, Bailey has seemed to implicitly suggest at multiple times that she supports regulated access to cannabis as a means of promoting public safety and health. Whether and how that implied position would influence federal policy if she’s confirmed and assumes the ONDCP director role is yet to be seen. On her social media, she’s previously shared links—without commentary—to news stories about a variety of marijuana-related issues. In addition to her focus on illicit cartel grows, she’s also posted about congressional and state-level legalization votes, staffers in the Biden administration being fired over past cannabis use, Democratic presidential candidates’ support for legalization, the advancement of cannabis banking legislation in Congress and state policy developments such as Alaska’s legalization of cannabis cafes. Photo courtesy of Chris Wallis // Side Pocket Images. The post Senator Blocks Confirmation Of Trump’s ‘Unqualified’ White House Drug Czar Pick Who Has Voiced Medical Marijuana Support appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net